• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CU6
Click for more information
0.52% $3.80

CLARITY PHARMACEUTICALS LTD - Charts / Financials

Market Cap $1.219B  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Clarity Pharmaceuticals Ltd is an Australia-based clinical-stage radiopharmaceutical... Clarity Pharmaceuticals Ltd is an Australia-based clinical-stage radiopharmaceutical company. The Company is focused on developing theranostic (therapy and imaging) products, based on its platform SAR Technology. It is progressing seven clinical trials with its three key products, SARTATE, SAR-bisPSMA, and SAR-Bombesin. SARTATE is developed for diagnosing, staging, and treating cancers that express somatostatin receptor 2 (SSTR2), including neuroblastoma and neuroendocrine tumors (NETs). SAR-bisPSMA is developed for diagnosing, staging, and treating cancers that express Prostate Specific Membrane Antigen (PSMA). SAR-Bombesin is developed for identifying and selecting patients for subsequent treatment of cancers that express a specific receptor called the gastrin releasing peptide receptor (GRPr), including breast cancer and prostate cancer. It has a diverse range of products in clinical trials, which address both large indications as well as rare and orphan indications of cancer.More

refresh Created with Sketch. REFRESH
Last update - 15.59pm 15/01/2025 (20 minute delay) ?
Day
Open $3.83   Day High $3.86   Day Low $3.77
Daily Volume 1158982
Bids   Sellers
Number Price Volume   Number Price Volume
2 $3.77 4002   1 $3.80 171

Data source: Refinitiv

(20min delay)
Last
$3.80 		Change
-0.020(0.52%) 		Mkt cap ! $1.219B
Open High Low Value Volume
$3.83 $3.86 $3.77 $4.410M 1.158M

Buyers (Bids)

No. Vol. Price($)
2 4002 $3.77
 

Sellers (Offers)

Price($) Vol. No.
$3.80 171 1
View Market Depth
Last trade - 16.10pm 15/01/2025 (20 minute delay) ?
Last
$3.80 		  Change
-0.020 ( 0.32 %)
Open High Low Volume
$3.83 $3.86 $3.77 146279
Last updated 15.59pm 15/01/2025 ?

Top Stories

Great Boulder de-risks Side Well project with 98.7% gold recovery for Mulga Bill

Great Boulder Resources Ltd has shown that high gold recoveries with moderate levels of cyanide consumption are possible from Mulga Bill
Gold Mountain shares up 50% on drill target definition at Salinas II lithium play Gold Mountain Resources Ltd has recorded a strong share market performance on the news based on soil sampling results
Week 2 Wrap: Insignia denies Brookfield bid; Star teetering; 1.5C breached & Samsung’s AI TVs It's been a strange week, and it's the first of the year (sort of.) Exxon's suing Twiggy; Samsung's got AI TVs. Then there's climate change.
HotCopper Highlights: Your most watched stocks for Week 2, 2025 Welcome back! It's 2025, and traders are looking for stockpicking opportunities. Here's what HotCopper users are watching.
ASX Market Update: Bourse inches higher after paring gains | January 15, 2025 The Discretionary sector has been leading the market higher, up 0.6%, followed by Real Estate, up 0.5%, and Financials, up 0.45%.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.